<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38470857</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>230</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Patient and Immunological Factors Associated With Delayed Clearance of Mucosal Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Symptom Persistence.</ArticleTitle><Pagination><StartPage>357</StartPage><EndPage>362</EndPage><MedlinePgn>357-362</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiae132</ELocationID><Abstract><AbstractText>Serial blood and mucosal samples were characterized for 102 participants enrolled a median of 7.0 days after coronavirus disease 2019 diagnosis. Mucosal RNA was detectable for a median of 31.5 (95% confidence interval [CI], 20.5-63.5) days, with persistence &#x2265;1 month associated with obesity (body mass index [BMI] &#x2265;30 kg/m2; odds ratio [OR], 3.9 [95% CI, 1.2-13.8]) but not age, sex, or chronic conditions. Fifteen participants had likely reinfection; lower serum anti-spike IgG levels were associated with reinfection risk. Nearly half of participants (47%) reported symptoms lasting &#x2265;2-3 months; persistence &#x2265;3 months was associated with BMI &#x2265;30 kg/m2 (OR, 4.2 [95% CI, 1.1-12.8]) and peak anti-spike and anti-nucleocapsid antibody levels.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Mars</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5619-2767</Identifier><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>Bryan R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Scientific Affairs, American Red Cross.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warden</LastName><ForeName>Donald E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Westat, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fink</LastName><ForeName>Rebecca V</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Westat, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saa</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Scientific Affairs, American Red Cross.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leddy</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulach-Vannoy</LastName><ForeName>Jackie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Scientific Affairs, American Red Cross.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krysztof</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Scientific Affairs, American Red Cross.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Alexandria N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Westat, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Germanio</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Debra A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>New York Blood Center Enterprises, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinman</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0003-0526-2088</Identifier><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>75N92019D00033</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN 75N92019D00032</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>National Institute of Allergy and Infectious Diseases</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="Y">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000084063" MajorTopicYN="N">Reinfection</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">obesity</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38470857</ArticleId><ArticleId IdType="pmc">PMC11326823</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiae132</ArticleId><ArticleId IdType="pii">7627276</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Flacco ME, Acuti Martellucci C, Baccolini V, et al. . Risk of reinfection and disease after SARS-CoV-2 primary infection: meta-analysis. Eur J Clin Invest 2022; 52:e13845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353414</ArticleId><ArticleId IdType="pubmed">35904405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa&#xe1; P, Fink RV, Bakkour S, et al. . Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma. J Clin Invest 2022; 132:e159876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9435642</ArticleId><ArticleId IdType="pubmed">35834347</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Schneider AM, Mehta A, et al. . SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J Clin Invest 2021; 131:e148635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245177</ArticleId><ArticleId IdType="pubmed">34196300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkour S, Sa&#xe1; P, Groves JA, et al. . Minipool testing for SARS-CoV-2 RNA in United States blood donors. Transfusion 2021; 61:2384&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">34046906</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Germanio C, Simmons G, Kelly K, et al. . SARS-CoV-2 antibody persistence in COVID -19 convalescent plasma donors: dependency on assay format and applicability to serosurveillance. Transfusion 2021; 61:2677&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447038</ArticleId><ArticleId IdType="pubmed">34121205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim L, Garg S, O&#x2019;Halloran A, et al. . Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)&#x2013;associated hospitalization surveillance network (COVID-NET). Clin Infect Dis 2021; 72:e206&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454425</ArticleId><ArticleId IdType="pubmed">32674114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Lu Y, Huang Y-M, et al. . Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism 2020; 113:154378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521361</ArticleId><ArticleId IdType="pubmed">33002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhao B, Qu Y, et al. . Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis 2020; 71:1937&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson MI, Arancibia-Carcamo CV, Auckland K, et al. . SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res 2020; 5:181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689603</ArticleId><ArticleId IdType="pubmed">33283055</ArticleId></ArticleIdList></Reference><Reference><Citation>Littleton SW. Impact of obesity on respiratory function: impact of obesity on respiratory function. Respirology 2012; 17:43&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22040049</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol 2020; 16:341&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187148</ArticleId><ArticleId IdType="pubmed">32327737</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Pekosz A, Park H-S, et al. . Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest 2020; 130:6141&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598041</ArticleId><ArticleId IdType="pubmed">32764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 2021; 53:737&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada Y, Sunada N, Honda H, et al. . Serial changes of long COVID symptoms and clinical utility of serum antibody titers for evaluation of long COVID. J Clin Med 2022; 11:1309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8911256</ArticleId><ArticleId IdType="pubmed">35268400</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>